In the final episode of our third series, we discuss Pharmacogenetics. Recorded with a live audience in Berlin, Germany. On the panel we have a wonderful range of guests including Professor and Head of Estonian Biobank, Lili Milani, CEO of Unique Patient Group, Sara Winn, Vita Dolžan, Head of the Pharmacogenetics Laboratory at the Faculty of Medicine at the University of Ljubljana, and Bill Newman, Clinical Geneticist and Vice President of the ESHG.
All content for Genetic Sounds is the property of The European Society of Human Genetics and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In the final episode of our third series, we discuss Pharmacogenetics. Recorded with a live audience in Berlin, Germany. On the panel we have a wonderful range of guests including Professor and Head of Estonian Biobank, Lili Milani, CEO of Unique Patient Group, Sara Winn, Vita Dolžan, Head of the Pharmacogenetics Laboratory at the Faculty of Medicine at the University of Ljubljana, and Bill Newman, Clinical Geneticist and Vice President of the ESHG.
In this episode, we discuss "What is a genetic syndrome?". We ask whether we still need ‘conditions’, or can we just have genes? A conversation with Leslie Biesecker, NIH Distinguished Investigator at the Center for Precision Health Research and Izzy Rundle, Engagement and Support Manager at SWAN UK (Syndrome Without a Name). Sofia Houge, from the European Society of Human Genetics also joins the conversation.
Genetic Sounds
In the final episode of our third series, we discuss Pharmacogenetics. Recorded with a live audience in Berlin, Germany. On the panel we have a wonderful range of guests including Professor and Head of Estonian Biobank, Lili Milani, CEO of Unique Patient Group, Sara Winn, Vita Dolžan, Head of the Pharmacogenetics Laboratory at the Faculty of Medicine at the University of Ljubljana, and Bill Newman, Clinical Geneticist and Vice President of the ESHG.
